6 years HbA1c, total cho-lesterol, TG,LDL cholesterol and AIP ratio were elevated but only total cholesterol and LDL choles-terol werestatistically significant. All the lipid parameters except HDL cholesterol were higher in subjects with HbA1c >7 % as com-pared to the group with HbA1c < 7%. Conclusion: The findings indicate that HbA1c can provideauxiliary information about theextent of cir-culating lipids and AIP, and can thus be used as a predictor of car-diovascular risk in diabetics " " />
Home|Journals Follow on Twitter| Subscribe to List

Directory for Medical Articles
 

Open Access

Original Article

Natl J Community Med. 2014; 5(1): 29-32


Can HbA1c Act as a Surrogate Marker for Cardiovascular Risk?

Manish B Patel, Wasimahmed M Sachora, Ashay R Pandya, Abhimanyu D Kothari, Jigar K Patel.

Abstract
"Aim: Glycosylated hemoglobin is a used marker for long-term glyce-mic control. This investigation is an attempt to evaluate the diagnos-tic value of HbA(1c) in predicting cardiovascular risk
Materials and methods:The study was conducted in V.S general hos-pital. 278 subjectsduringMay 2012 to October 2012, were included in the study. Details regarding to age, gender, duration of diabetes, were taken. Venous blood samples were collected and analyzed for glyco-sylated hemoglobin (HbA1c), fast-ing plasma glucose (FPG), Total Cholesterol, Triglycerides, HDL-C and LDL-C and AIP
Results:The total cholesterol and LDL cholesterol were significantly higher in females as compared to male diabetics. TG levels and AIP ratio were raised in the subjects 55 years. In cases with duration of di-abetes > 6 years HbA1c, total cho-lesterol, TG,LDL cholesterol and AIP ratio were elevated but only total cholesterol and LDL choles-terol werestatistically significant. All the lipid parameters except HDL cholesterol were higher in subjects with HbA1c >7 % as com-pared to the group with HbA1c < 7%.
Conclusion: The findings indicate that HbA1c can provideauxiliary information about theextent of cir-culating lipids and AIP, and can thus be used as a predictor of car-diovascular risk in diabetics
"

Key words: Diabetes, Dyslipidemia, HbA1c, AIP



Share this Article


Advertisement
Journal of Molecular Pathophysiology

SUBMIT YOUR ARTICLE NOW


ScopeMed.com
ScopeMed Home
Follow ScopeMed on Twitter
BiblioCAM
Author Tools
eJPort Journal Hosting
About ScopeMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Scopemed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
ScopeMed is a Database Service for Scientific Publications. Copyright ScopeMed Information Services.
Scopemed Buttons